Fairman Group’s Abbott ABT Stock Holding History

Fairman Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50	Closed	-$5.66K	–	260
2024 Q4	$5.66K	Sell	50 -51	-50%	-$5.89K	﹤0.01%	185
2024 Q3	$11.5K	Hold	101	–	–	0.01%	164
2024 Q2	$10.5K	Hold	101	–	–	0.01%	168
2024 Q1	$11.5K	Hold	101	–	–	0.01%	154
2023 Q4	$11.1K	Buy	+101	New	+$10.1K	0.01%	156

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fairman Group's ABT Position: Q1 2025 in Review

Fairman Group sold out of Abbott (ABT) in Q1 2025, closing a stake of 50 shares — an estimated $5.66K sold.

Fairman Group first reported a position in ABT in Q4 2023 and held it in 5 quarters. The position peaked at $11.5K in Q3 2024. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

Fairman Group reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
Fairman Group sold 50 Abbott shares in Q1 2025, an estimated $5.66K.
Fairman Group first reported a position in Abbott in Q4 2023 and held it in 5 quarters.
Fairman Group's Abbott position peaked at $11.5K in Q3 2024.
3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.